P-3: Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in

$287,657P50FY2005CANIH

Mayo Clinic, Rochester MN

Investigators

Sandra Jane Gendler

Linked publications, trials & patents

Paper 39764121 Paper 39516069 Paper 39495297 Paper 39488595 Paper 39445795 Paper 39317201 Paper 39281752 Paper 39266789 Paper 39259185 Paper 39142283 Paper 39030393 Paper 38965614 Paper 38886818 Paper 38858721 Paper 38854136 Paper 38752717 Paper 38675909 Paper 38636338 Paper 38621195 Paper 38585884 Paper 38563834 Paper 38553633 Paper 38496424 Paper 38417439 Paper 38234757 Paper 38230434 Paper 38191790 Paper 38172536 Paper 38018486 Paper 37910295 Paper 37878154 Paper 37679505 Paper 37674722 Paper 37608772 Paper 37608771 Paper 37559094 Paper 37451831 Paper 37449874 Paper 37401034 Paper 37382948 Paper 37380569 Paper 37333340 Paper 37307602 Paper 37253507 Paper 37253112 Paper 37226243 Paper 37210429 Paper 37072398 Paper 37004493 Paper 36993608 Paper 36824750 Paper 36823213 Paper 36703164 Paper 36689693 Paper 36647342 Paper 36635351 Paper 36623243 Paper 36469363 Paper 36458203 Paper 36380012 Paper 36205748 Paper 36114500 Paper 36077757 Paper 36045271 Paper 35864174 Paper 35836268 Paper 35776260 Paper 35736817 Paper 35665744 Paper 35653140 Paper 35601026 Paper 35569077 Paper 35459234 Paper 35358345 Paper 35177654 Paper 35082299 Paper 35042965 Paper 34906479 Paper 34902335 Paper 34843374 Paper 34672684 Paper 34667110 Paper 34611289 Paper 34587243 Paper 34480554 Paper 34428048 Paper 34304271 Paper 34292776 Paper 34226744 Paper 34218359 Paper 34196308 Paper 34108182 Paper 34101624 Paper 34101481 Paper 34078650 Trial NCT05703399 Trial NCT04897009 Trial NCT04294225 Trial NCT03941730 Trial NCT01327781

View original record on NIH RePORTER →

P-3: Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in · GrantIndex